Table 3.

Hazard Ratios (HR) and 95% Confidence Intervals (CI) for Risk of Cancer after ART among Women without Prior ART Treatment by Age at Cycle Start^*

		All Cancers			Endocrine			Melanoma			Breast			Ovary			Uterus			All Female Genital
N (number of cancers)		(460)			(71)			(42)			(185)			(21)			(26)			(67)
		HR	95% CI	P Value*	HR	95% CI	P Value	HR	95% CI	P Value	HR	95% CI	P Value	HR	95% CI	P Value	HR	95% CI	P Value	HR	95% CI	P Value
Age at	18-29	1.00	Reference	<0.0001	1.00	Reference	0.59	1.00	Reference	0.75	1.00	Reference	<0.0001	1.00	Reference	0.31	1.00	Reference	0.01	1.00	Reference	0.01
Cycle Start	30-34	1.27	0.85, 1.92		0.96	0.43, 2.16		0.88	0.32, 2.42		2.95	1.02, 8.65		1.88	0.21, 17.57		2.74	0.33, 23.74		1.52	0.49, 4.76
	35-37	1.92	1.28, 2.90		1.16	0.51, 2.70		0.71	0.23, 2.25		5.59	1.98, 16.15		4.05	0.49, 35.18		0.66	0.04, 11.10		2.06	0.66, 6.54
	38-40	2.86	1.92, 4.27		1.36	0.59, 3.16		1.28	0.45, 3.68		10.43	3.76, 29.51		1.64	0.15, 19.08		3.06	0.34, 28.72		2.25	0.72, 7.26
	41-43	2.87	1.89, 4.39		0.81	0.29, 2.32		1.49	0.50, 4.57		11.61	4.13, 33.31		3.54	0.37, 35.88		10.01	1.26, 82.78		4.55	1.51, 14.09
	44-64	4.88	3.17, 7.59		1.90	0.70, 5.24		1.36	0.34, 5.65		23.20	8.23, 66.86		7.68	0.79, 78.24		9.30	1.03, 87.78		5.24	1.57, 17.95

^*Models adjusted for State, and year of ART treatment